Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Schwerin – page 2

89 clinical trials in Schwerin, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Schwerin at a glance
89
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

89 trials in Schwerin

Open in trial search

Graves' disease

Recruiting

Long-Term Study of Imeroprubart in Adults With Graves' Disease

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

A Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Seaport Therapeutics Inc.

A study of brenipatide compared to placebo for the treatment of adults with alcohol use disorder

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.

Prostate cancer

Recruiting

A study of saruparib with radiotherapy and hormone therapy for men with high-risk prostate cancer who have a BRCA gene mutation

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:AstraZeneca AB

A Study of Belzutifan and Zanzalintinib Compared to Cabozantinib in Patients with Advanced Kidney Cancer that Returned After Previous Treatment

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Belzutifan
  • Sponsor:Merck Sharp & Dohme LLC

A Study of Brexanolone Caprilcerbate for Adults with Major Depressive Disorder With or Without Anxious Distress

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Seaport Therapeutics Inc.

Breast cancer+1

Recruiting

Study of inavolisib, letrozole and ribociclib in untreated early-stage breast cancer patients with PIK3CA mutation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Inavolisib
  • Sponsor:F. Hoffmann-La Roche AG

Graves' disease

Recruiting

Study on the Effectiveness and Safety of IMVT-1402 for Adults with Graves' Disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Imeroprubart
  • Sponsor:Immunovant Sciences GmbH

Study on Pre-Operative Chemotherapy with Disodium Folinate, Oxaliplatin, and Fluorouracil for Patients with Advanced Resectable Colon Cancer

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Charite Universitaetsmedizin Berlin KöR

Study on the Effectiveness of E. coli DSM 17252 for Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:SymbioPharm GmbH

Glioma

Recruiting

Study of Temozolomide and Lomustine Followed by Radiotherapy versus Standard Treatment in Patients with Newly Diagnosed Grade 2 or 3 Glioma

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Lomustine
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Medulloblastoma

Recruiting

Study on Medulloblastoma Treatment in Children Aged 3-5 Using Carboplatin and Drug Combination

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:University Medical Center Hamburg-Eppendorf

Other cities in Germany

The busiest research cities in the country

All 518 cities in Germany

Clinical research in Schwerin

What the registry says about research in the country

01 Respiratory and Viral Research

Studies focusing on respiratory infections including trials evaluating vaccines against RSV and human metapneumovirus. Additional research examines improved influenza protection in adults over 50 years with stable comorbidities.

  • RSV and hMPV Prevention
  • Influenza Vaccination
  • Immunogenicity Studies
02 Dermatology Studies

Multiple investigations into treatments for plaque psoriasis, with emphasis on evaluating new therapeutic options for moderate to severe cases. Research includes long-term safety assessments and comparative efficacy studies.

  • Moderate to Severe Psoriasis
  • Novel Treatment Evaluation
  • Long-term Safety Studies
03 Oncology Research

Comprehensive cancer studies including breast cancer, colon cancer, and lymphoma treatments. Trials evaluate pre-operative therapies, immunotherapy combinations, and specialized protocols for pediatric patients.

  • Triple-Negative Breast Cancer
  • Colon Cancer Treatment
  • B-cell Lymphoma Therapies
04 Neurological Disorders

Research focusing on Alzheimer's Disease, migraine prevention, and neurological conditions. Studies evaluate new therapeutic approaches and compare treatment efficacy with existing medications.

  • Early Alzheimer's Treatment
  • Migraine Prevention
  • Inflammatory Biomarkers
05 Mental Health Studies

Extensive research into Major Depressive Disorder and ADHD, investigating new therapeutic approaches and long-term treatment outcomes. Studies include both adult and adolescent populations.

  • Depression Treatment
  • ADHD Management
  • Long-term Safety Assessments
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.